More on SCNX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-952.6% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Scienture Holdings (NQ:SCNX)
Delayed: 3.36 -0.02 (0.59%)
Prev. Close $3.38  
Open$3.38 
52 Wk High$ 
52 Wk Low$ 
Day High$3.42 
Day Low$3.25 
P/E N/A  
EPS$ 
Volume24,167 

Friends, Peers and Foes (?): WGRX (more...)

Oct 13, 2026 08:05 AM Scienture reports $1.22M in preliminary Q3 2026 revenue
Oct 13, 2026 08:05 AM SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Oct 7, 2026 05:30 PM Form 8-K Scienture Holdings, Inc. For: Oct 05
Oct 2, 2026 08:06 AM Scienture's Arbli added to formularies at three pediatric hospitals
Oct 2, 2026 08:05 AM SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
Sep 30, 2026 04:05 PM Scienture Holdings announces 1-for-25 reverse stock split
Sep 30, 2026 04:05 PM Scienture Holdings, Inc. Announces Reverse Stock Split
Sep 22, 2026 05:10 PM Form 8-K Scienture Holdings, Inc. For: Sep 14
Sep 22, 2026 08:16 AM Scienture signs deal to sell Rezenopy at 2,000 addiction clinics
Sep 22, 2026 08:15 AM SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
View All Articles

Entities mentioned with SCNX

View All Entities